Trump administration withdraws FDA plan to ban menthol cigarettes
The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and ...
Hosted on MSN41m
What Does the FDA’s New Definition of ‘Healthy’ Mean for You?
Finding healthier foods just got easier, thanks to the FDA’s updated guidelines for what qualifies as ‘healthy.’ Learn the ...
FDA releases update on chicken broth recall at Ga. Walmarts
The Food and Drug Administration has released an update on a recall for chicken broth sold at Georgia Walmarts.
Rolling Out3h
FDA unveils 8 critical safety measures for berry industry
FDA introduces comprehensive safety measures targeting norovirus and hepatitis A in fresh and frozen berries, addressing ...
Dip Recall Update as FDA Sets Risk Class
The spinach artichoke dip mix was recalled due to it having been underprocessed, the Food and Drug Administration said.
FOX 5 Atlanta24m
Trump Administration freezes CDC, other federal health agencies' communications
The Trump Administration has frozen many federal health agencies’ communications with the public until at least the end of ...
Undercurrent News58m
FDA targets two foreign seafood processors, one US importer for HACCP violations
The US Food and Drug Administration hit two foreign seafood processors and one Buffalo, New York-based seafood importer with warning letters this week ...
CNN on MSN9d
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
FDA bans Red No. 3 in food and ingested drugs. Here's when it has to be phased out by
Red No. 3, also known as erythrosine, is a color additive made from petroleum that gives foods and drinks a bright, ...
Scientific American4h
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
FDA and EMA review Biogen's higher dose SMA drug
CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...